Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Busch

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|June 30, 2004
The utility of insulin glargine in the treatment of diabetes mellitusJeffrey Stroup, Michael P Kane, Robert S Busch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2003
Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch UltraJason Demers, Michael P Kane, Gary Bakst, et al.
Journal of the American Pharmacists Association : Japha|May 19, 2019
A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive reportJenna L McGreevy, Michael P Kane, Robert S Busch, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|October 8, 2014
A clinical perspective of canagliflozin in the management of type 2 diabetes mellitusAnneMarie Nardolillo, Michael P Kane, Robert S Busch, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 27, 2015
SGLT-2 INHIBITOR THERAPY ADDED TO GLP-1 AGONIST THERAPY IN THE MANAGEMENT OF T2DMRachel M Saroka, Michael P Kane, Robert S Busch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 20, 2006
Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch UltraShannon M Rivers, Michael P Kane, Gary Bakst, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intoleranceShannon M Rivers, Michael P Kane, Robert S Busch, et al.
Diabetes Technology & Therapeutics|February 12, 2008
A glucose meter accuracy and precision comparison: the FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD LogicLinda E Thomas, Michael P Kane, Gary Bakst, et al.
Diabetes Technology & Therapeutics|September 22, 2009
Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure ProCatherine A Sheffield, Michael P Kane, Gary Bakst, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 9, 2008
Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitusCatherine A Sheffield, Michael P Kane, Robert S Busch, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|June 30, 2004
The utility of insulin glargine in the treatment of diabetes mellitusJeffrey Stroup, Michael P Kane, Robert S Busch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2003
Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch UltraJason Demers, Michael P Kane, Gary Bakst, et al.
Journal of the American Pharmacists Association : Japha|May 19, 2019
A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive reportJenna L McGreevy, Michael P Kane, Robert S Busch, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|October 8, 2014
A clinical perspective of canagliflozin in the management of type 2 diabetes mellitusAnneMarie Nardolillo, Michael P Kane, Robert S Busch, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 27, 2015
SGLT-2 INHIBITOR THERAPY ADDED TO GLP-1 AGONIST THERAPY IN THE MANAGEMENT OF T2DMRachel M Saroka, Michael P Kane, Robert S Busch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 20, 2006
Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch UltraShannon M Rivers, Michael P Kane, Gary Bakst, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intoleranceShannon M Rivers, Michael P Kane, Robert S Busch, et al.
Diabetes Technology & Therapeutics|February 12, 2008
A glucose meter accuracy and precision comparison: the FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD LogicLinda E Thomas, Michael P Kane, Gary Bakst, et al.
Diabetes Technology & Therapeutics|September 22, 2009
Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure ProCatherine A Sheffield, Michael P Kane, Gary Bakst, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 9, 2008
Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitusCatherine A Sheffield, Michael P Kane, Robert S Busch, et al.
Pageof 3